IFYtrox-SB-750
Description_Effects
IFYtrox-SB-750 is a broad-spectrum injectable antibiotic combination consisting of Ceftriaxone (500 mg) and Sulbactam (250 mg). It is used to treat a wide range of bacterial infections effectively, especially those caused by beta-lactamase-producing resistant organisms. Ceftriaxone is a third-generation cephalosporin antibiotic that works by inhibiting the synthesis of bacterial cell walls. This disrupts the structural integrity of the bacteria, causing their destruction and preventing the spread of infection. Sulbactam is a beta-lactamase inhibitor that protects Ceftriaxone from being broken down by enzymes produced by certain resistant bacteria. This combination extends the antibacterial spectrum of Ceftriaxone and makes it effective against organisms that would otherwise be resistant. IFYtrox-SB-750 is commonly prescribed for respiratory tract infections, urinary tract infections, abdominal infections, skin and soft tissue infections, bone and joint infections, and septicemia. It is administered either intramuscularly or intravenously by a healthcare professional, depending on the severity and type of infection. The injection is generally well tolerated, though mild side effects such as pain at the injection site, diarrhea, rash, or nausea may occur. Completing the full course of treatment is essential to ensure complete eradication of the infection and to prevent antibiotic resistance.
